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Aberrant access to genetic information disrupts cellular
homeostasis and can lead to cancer development. One molecu-
lar mechanism that regulates access to genetic information
includes recognition of histone modifications, which is carried
out by protein modules that interact with chromatin and serve
as landing pads for enzymatic activities that regulate gene
expression. The ING3 tumor suppressor protein contains a
plant homeodomain (PHD) that reads the epigenetic code via
recognition of histoneH3 tri-methylated at lysine 4 (H3K4me3),
and this domain is lost or mutated in various human cancers.
However, themolecularmechanisms targeting ING3 tohistones
and the role of this interaction in the cell remain elusive. Thus,
we employed biochemical and structural biology approaches to
investigate the interaction of the ING3 PHD finger (ING3PHD)
with the active transcription mark H3K4me3. Our results dem-
onstrate that association of the ING3PHD with H3K4me3 is in
the sub-micromolar range (KD ranging between 0.63 and 0.93
M) and is about 200-fold stronger than with the unmodified
histone H3. NMR and computational studies revealed an aro-
matic cage composed of Tyr-362, Ser-369, and Trp-385 that
accommodate the tri-methylated side chain of H3K4. Muta-
tional analysis confirmed the critical importance of Tyr-362 and
Trp-385 in mediating the ING3PHD-H3K4me3 interaction.
Finally, the biological relevance of ING3PHD-H3K4me3 binding
was demonstrated by the failure of ING3PHDmutant proteins to
enhance ING3-mediated DNA damage-dependent cell death.
Together, our results reveal the molecular mechanism of
H3K4me3 selection by the ING3PHD and suggest that this inter-
action is important for mediating ING3 tumor suppressive
activities.
Although the human genome was sequenced over a decade
ago and its structure has been investigated for nearly half a
century, the molecular mechanisms that regulate access to
genetic information remain largely unknown. One recently
identified mechanism is based on the physical association of
chromatin reader domains with the histone scaffolding pro-
teins that condense the genome within the nucleus of the cell.
Essentially, the DNA strands of the genome are spooled around
histone octamers (two copies of each histone H2A, H2B, H3,
and H4) to form nucleosomes, the basic unit of chromatin.
These histone proteins harbor an N-terminal tail that pro-
trudes outside of the core nucleosome (1). The histone tails are
readily available for post-translational modifications, such as
lysine acetylation and methylation. Methyltransferases modify
lysine in a stepwise manner to generate mono- (Kme1), di-
(Kme2), or tri-methylated (Kme3) lysine. Each methylation
state can be recognized by specific histone mark reader mod-
ules and thus lead to divergent biological outcomes. Specifi-
cally, reader domains serve as bridges between chromatin and
enzymatic activities that open or close the structure of the chro-
matin, thereby regulating access to genetic information and
control gene expression. Aberrant access to genetic informa-
tion leads to pathologies ranging from cancer to neurological
disorders.
Several histone mark readers have been described over the
last 15 years, with the chromodomain of the heterochromatin
protein HP1 that binds to histone H3 tri-methylated on lysine
9 (H3K9me3) (2) as a prime example. Since then, other reader
domains have been discovered, including H3K9me3 readers
(ADD, WD40, plant homeodomain, and chromodomains);
H3K36me3 readers (tudor, chromobarrel, and PWWP do-
mains); H4K20me2 readers (tandem tudor domain and BAH
domain); and H3K4me3 readers (plant homeodomains, tan-
dem tutor domains, double chromodomains, and the zf-CW
domain) (3, 4). The plant homeodomain (PHD7 finger) is found
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in several nuclear proteins, but their function was first
described in the INhibitor of Growth (ING) family of tumor
suppressors. The foundingmember, p33ING1b,was cloned in a
genetic suppressor element screen (5). Then, ING2 (6), ING3
(7, 8), ING4 (9–11), and ING5 (9) were identified, essentially
based on sequence similaritieswith p33ING1b. The PHD finger
of ING proteins was shown to mediate interactions with
H3K4me3 at the transcriptional start site of genes to stabilize
enzymatic activities that regulate access to genetic information
(12). Specifically, ING4 binds H3K4me3 at the transcriptional
start site to recruit histone acetyltransferase activity and facili-
tate access to genetic information (13), whereas ING2 bridges
histone deacetylase activity toH3K4me3 at transcriptional start
site to silence gene expression (14).
ING proteins are broadly lost or mutated in various types of
human cancers (15, 16). Overexpression studies suggest their
involvement in preventing cellular proliferation, while enhanc-
ing cell contact inhibition andDNAdamage-induced cell death
(12). A comprehensive biochemical characterization of ING
proteins demonstrated that p33ING1b and ING2 associate
with the mSIN3A-HDAC1 histone deacetylase complex (17,
18), whereas ING3, ING4, and ING5 are found in histone
acetyltransferase (HAT) complexes (17). Specifically, ING3
associates with the TIP60 (Tat-interacting protein of 60 kDa)
complex (17, 19), ING4 with the HBO1-JADE complex (17),
and ING5 with both HBO1-JADE and MOZ-BRPF complexes
(17). Thus, p33ING1b and ING2 are believed to primarily func-
tion as transcriptional repressors via histone deacetylase activ-
ity, whereas ING3, ING4, and ING5 are mainly involved in
transcriptional activation via associated HAT activities.
ING3 functions in the multiprotein TIP60 HAT complex,
which also includes the ATPases EP400, RUVBL1 (Pontin), and
RUVBL2 (Reptin), TRRAP, the bromodomain protein BRD8,
the polycomb proteins EPC1 and EPCys-2, the DNA methyl-
transferase-associated protein DMAP1, actin, and the actin-
like protein BAF53A (ACTL6A), the mortality factor MRG15
(MORF4L1),MEAF6, andGAS41 (YEATS4) (17). Interestingly,
like ING4 (13), TIP60, RUVBL1, and RUVBL2 are involved in
the DNA damage response (20, 21). Moreover, the RUVBL1
and RUVBL2 proteins in the ING3 complex regulate hypoxia
signaling much the same as observed with ING4 (22–25), sug-
gesting possible redundant or complementary functions
between ING3 and ING4 in the regulation of cellular stress
responses. Finally, the components of the ING3 complex
described above were recently found to associate with the his-
tone chaperon ANP32E and the histone variant H2AZ (26).
Although the role of ING3 in histone exchange remains elusive,
ING3 is required along with EPC1 for acetylation of nucleo-
somes by TIP60 (19).
Importantly, ING2 was found to interact with histone H3.
Specifically, the PHD of ING2 binds to H3K4me3 via a conserved
aromatic cage (14, 27). The PHD finger-H3K4me3 interaction is
critical for both ING2 (14) and ING4 (13) to associate with tran-
scriptional start sites and repress or activate gene expression,
respectively. Furthermore, the ING4PHD-H3K4me3 interaction
was demonstrated to be essential for ING4 tumor suppressive
activities, including enhancing DNA damage-induced cell death,
inhibition of cellular proliferation, and colony formation (13).
Thus, the ability of the PHD finger domain to bridge INGproteins
to H3K4me3 is thought to be critical for the tumor suppressor
activity of all ING family proteins.
The ING3 locus is lost or mutated in several human cancers.
Notably, frequent loss of heterozygosity is detected at the ING3
locus, 7q31, in invasive epithelial ovarian carcinomas (28, 29),
prostate (30), colorectal (31), as well as human head and neck
cancers (8). The 7q31 region contains four candidate tumor
suppressor genes, CAV1, CAVal-2, ST7, and ING3. Because
mutations in the PHD domain of ING3 are also reported in the
genomes of various cancers (Cys-376 (frameshift), D380H, and
H387P (33)), we decided to investigate the molecular mecha-
nisms that regulate the association of ING3 with histone post-
translational modifications. ITC and nuclear magnetic reso-
nance (NMR) experiments demonstrate that the ING3PHD
selects for H3K4me3H3K4me2H3K4me1 unmodified
histone H3 and identified residues critical for ligand coordina-
tion. These results are further supported bymolecular dynamic
(MD) simulation studies of the ING3PHD with modified and
unmodified histone H3 and H4 peptides. The trajectory analy-
sis of our MD simulations revealed a conserved aromatic cage
composed of residues Tyr-362, Ser-369, and Trp-385, which
imparts the affinity and specificity for histoneH3methylated at
lysine 4. A structural comparison of the time-averaged struc-
ture from the MD simulation of the ING3PHD-H3K4me3 com-
plex with x-ray crystal structures of the other ING familymem-
ber proteins bound to H3K4me3 revealed that the mechanism
of histone ligand binding is universally conserved within this
protein family. Furthermore, we found that full-length ING3
proteins defective inH3K4me3 recognition are still able to form
a complexwith theTIP60HAT, and cell-based assays show that
the ING3-H3K4me3 interaction is required for DNA damage-
induced cell death. These data illustrate for the first time that
histone recognition by the PHD finger region of ING3 is crucial
for its activity as a candidate tumor suppressor protein. Inter-
estingly, increased copy number of ING3 along with overex-
pression and deregulation of ING3 have recently been linked to
poor outcomes in prostate cancer patients and castrate-resis-
tant prostate cancer cell lines (34–36). This suggests that ING3
may suppress tumor formation in some cases while promoting
cancer in others. Together, our results illustrate the structure
and function of the ING3 PHD finger domain in histone recog-
nition and in regulating the biological activity of the ING3 pro-
tein, which will be important for the development of new epi-
genetic therapies aimed a modulating the role of ING3 in
disease.
Results
ING3PHD Recognizes Methylated Histone H3—The ING3
subunit of the TIP60HAT complex contains a C-terminal PHD
finger. PHD finger domains are generally known to recognize
methylated lysine on histone tails, and the closely related ING4
and ING5 tumor suppressor proteins have been shown to rec-
ognize H3K4me3 through their PHD domains (13, 37, 38). To
determine the binding specificity and affinity of the ING3PHD,
we used a combination of biochemical and biophysicalmethods
to screen the PHD finger against a variety of methylated and
unmodified histone tail peptides. We carried out tryptophan
Histone Recognition by the ING3 PHD Finger
AUGUST 26, 2016•VOLUME 291•NUMBER 35 JOURNAL OF BIOLOGICAL CHEMISTRY 18327
fluorescence experiments to test the binding of ING3PHD to
histone peptides, H3K4me3 (residues 1–12), H3K4me2 (resi-
dues 1–12), H3K4me1 (residues 1–12), H3 unmodified (resi-
dues 1–12), and H4 unmodified (residues 1–12). Tryptophan
fluorescence is an ideal method to investigate the ING3PHD-
histone interactions because the binding pocket of the
ING3PHD contains two tryptophan residues involved in histone
coordination. As seen with other ING PHD finger proteins,
ING3PHD preferably recognized histone H3 that was tri-meth-
ylated on lysine 4 (KD  0.63 M), and the histone peptide
binding affinity decreased in conjunction with the methylation
status of lysine 4 (KD 4.05M for H3K4me2 and 21.45M for
H3K4me1) (Table 1). Unmodified histone H3 bound the weak-
est with a binding coefficient of 131.6 M, and no binding was
detected between the ING3PHD and histone H4.
The dissociation constants of the ING3PHD with the histone
H3 and histone H4 peptides were also analyzed by ITC experi-
ments (Fig. 1), and the results are included in Table 1. The KD
values determined from the ITC titration data confirmed that
the H3K4me3 bound to the ING3PHD with the highest affinity
(0.93 M), followed by H3K4me2 (2.99 M), H3K4me2 (23.24
M), and H3 unmodified (180.6 M), consistent with the tryp-
tophan fluorescence data shown in Table 1. No binding was
observed between ING3PHD and the unmodified histone H4
peptide. Our results demonstrate that the ING3 PHD domain
preferentially binds to H3K4me3, consistent with the other
ING PHD finger proteins (13, 14, 27, 37, 39).
Chemical Shift Mapping of the ING3 Binding Pocket—To
outline the specific interactions between the histone peptide
ligands and the ING3PHD binding pocket, we carried out
nuclear magnetic resonance (NMR) experiments. The back-
bone assignments of the ING3PHD finger were obtained from
the 15N,13C double-labeled ING3PHD using the ADAPT-NMR
program at the NMRFAM facility in Madison, WI, which
allowed for rapid data collection and assignment of the NMR
spectra (Fig. 2A). To confirm recognition of the histone tail
peptides observed by tryptophan fluorescence and ITC, the
1H-15N heteronuclear single quantum coherence (HSQC)
spectra of the uniformly 15N-labeled ING3 PHD finger were
recorded in the absence and presence of the following histone
tail peptides: unmodified histone H3 (residues 1–12), unmodi-
fied histoneH4 (residues 4–17), andH3K4me1,H3K4me2, and
H3K4me2 (residues 1–12). Chemical shift perturbations were
induced in the ING3PHD upon addition of unmodified H3,
H3K4me1, H3K4me2, and H3K4me3 (Fig. 2B). No significant
resonance shifts were observed upon the addition of unmodi-
fied histone H4 peptide. This pattern of histone recognition is
similar to the recognition of the histone tails by other INGPHD
finger proteins (13, 37) and confirms a strong interaction of the
ING3PHD domain with methylated histone H3 tails.
The chemical shift perturbations observed upon binding of
the H3K4me3 histone peptide were used to map the binding
pocket of the ING3 PHD finger. The normalized changes in
chemical shift from the NMR HSQC spectrum were plotted as
a bar graph to show the amino acid residues most affected by
addition of the H3K4me3 histone tail peptide in a 1:2.61
ING3PHD-to-peptide ratio. The largest chemical shifts (changes
greater than 0.4 ppm) are shown in red, and changes of0.3 or
0.2 ppm are shown in orange and yellow, respectively (Fig.
2C). Nine amino acidswithin the ING3PHD showed large chem-
ical shift changes upon addition of the H3K4me3 histone
ligand, including Tyr-8, Tyr-16, Glu-18, Val-20, Cys-22, Ile-29,
Glu-30, Trp-31, and Lys-46, indicating that these residues are
directly or indirectly involved in ligand binding. Mapping the
position of these amino acids onto the surface of the native
ING3PHD structure (PDB code 1X4I) reveals that there are two
adjacent ligand coordination regions on the surface of the PHD
finger (Fig. 2D). The first group of residues with large chemical
shift changes is clustered around Trp-31, which makes up the
side of the aromatic cage responsible for coordination of the
tri-methylated lysine in other PHD finger proteins, including
ING4 and ING5 (13, 37, 40). The second group of residues is
located near Trp-47 and comprises a potential binding site for
the N terminus of the histone H3 tail, which in the ING5PHD
(PDB code 3C6W) structure was a region critical for ligand
recognition and coordination (37). Notably, the residues show-
ing the largest chemical shift changes in the PHD binding
pocket are conserved with the ligand-coordinating residues
observed in the ING4 and ING5 crystal structures bound to
H3K4me3 (13, 37, 40) (also see the sequence alignment in Fig.
3A). These include Trp-47 , Tyr-8, and Ser-15, which make up
the aromatic cage in the ING5PHD structure (37). Residue Cys-
22, which shows the largest chemical shift change of any resi-
due, is one of the conserved cysteines responsible for coordi-
nating one of the two zinc ions in the ING3PHD finger. In the
ING5PHD structure, the residue conserved with Cys-22 (Cys-
202) makes an important hydrogen bond contact to Arg-2 in
theH3K4me3 histone tail peptide, and ourNMR chemical shift
data (in combination with our MD simulation data, Fig. 3B)
indicate thatCys-22 likelymakes a large conformational change
moving from a more buried position to the surface of the
ING3PHD binding pocket upon ligand binding.
Molecular Dynamic (MD) Simulations of Histone Ligand
Binding—Because our attempts to crystallize the H3K4me3
histone peptide in complex with the ING3 PHD finger were
unsuccessful, we used MD simulations to further investigate
TABLE 1
Dissociation constants of the ING3PHD fingerwith post-translationallymodified histone peptides asmeasuredby tryptophan fluorescence and ITC
Histone peptide Sequence Trp fluorescenceKD ITCKD
M M
H3K4me3(1–12) ARTKme3QTARKSTG 0.63 0.11 0.93 0.04
H3K4me2(1–12) ARTKme2QTARKSTG 4.05 0.53 2.99 0.33
H3K4me1(1–12) ARTKme1QTARKSTG 21.45 3.51 23.24 0.80
H3 unmodified(1–12) ARTKQTARKSTG 131.57 13.48 180.62 19.17
H4 unmodified(4–17) GKGGKGLGKGGAKR NAa No binding
aNA, not available.
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the ING3PHD-histone ligand interactions. The simulations
were carried out for the experimentally studied peptides bound
to ING3 to correlate differences in the binding affinities mea-
sured among histone ligands and specific molecular interac-
tions observed in the protein-ligand complexes. All the
peptides used in MD simulations were protonated on their
N terminus (NH3) and amidated on the C terminus to repre-
sent the structures of the peptides used in the in vitro experi-
ments. The initial MD simulation structures of the methylated
histoneH3peptides in complexwith the ING3PHDproteinwere
obtained by flexible docking of each of the four histone peptides
listed in Table 1 to the ING3PHD using the FlexPepDock pro-
gram (41, 42) from Rosetta commons (43). The initial approx-
imate binding poses for FlexPepDockwere taken from the x-ray
crystal structures of the ING4PHD and ING5PHD proteins in
complex with H3K4me3 peptides (PDB codes 2PNX and
3C6W, respectively). Both ING4PHD and ING5PHD share very
high sequence and structural identities with the ING3PHD,
especially among the binding site residues (Fig. 3A) (40).
Because of the absence of experimental structures for related
PHD finger proteins bound to the unmodified histone H4 pep-
tide, the initial FlexPepDock binding pose for this ligand was
obtained by docking histone H4 using the Hex webserver (44),
which does not require an initial approximate bound confor-
mation of the peptide. Then docking of the histone H4 peptide
was refined in FlexPepDock, so that the top scored complex of
H3K4me2
KD = 2.99 ± 0.33 μM
H3K4me3
KD = 0.93 ± 0.04 μM H3K4me1
KD = 23.24 ± 0.80 μM
H4 unmodified
KD = no binding
A B C
D E
H3 unmodified
KD = 180.6 ± 19.2 μM 
F
H3K9me3
KD = 396.9 ± 41.7 μM
FIGURE 1. ITCmeasurement of the interaction between thewild-type ING3 PHD finger andmethylated or unmodified histone peptides. A–F, exother-
mic ITC enthalpy plots for the bindingof the ING3PHD finger toH3K4me3, H3K4me2, H3K4me1, H3unmodified, H3K9me3, andH4unmodified. The calculated
binding constants are indicated.
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each peptide generated with FlexPepDock could be used as the
starting point for MD simulations.
The MD simulations, which were run using the Amber14
package for 10 ns under isobaric and isothermal conditions,
provided detailed insights into the molecular interactions
between the ING3PHD and its histone ligands (Tables 2 and 3).
The ING3PHD domain is a typical PHD finger fold with two
structural Zn2 atoms that are coordinated by a conserved pat-
tern of cysteine and histidine residues (Zn1-CCCC and Zn2-
CCCH) with tetrahedral geometry. Coordination of the zinc
ions by the Cys4-His-Cys3 consensus sequence stabilizes the
three loop regions of the PHD finger and is essential for folding
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FIGURE 2. Interaction of the ING3 PHD finger with histone ligands. A, two-dimensional 1H-15N HSQC spectra of 15N-labeled ING3 PHD finger with the
complete HSQC assignments labeled. B, superimposed 1H-15N HSQC spectra of the 0.5mM ING3 PHD finger, collected during titrating in the indicated histone
peptides. The spectra are color-coded according to the protein/peptide ratio. C, histogram of normalized 1H-15N chemical shift changes in backbone amides
of the ING3PHD fingeruponadditionof theH3K4me3peptide. Chemical shift changeswere from0.2 to0.3ppm(yellow), from0.3 to0.4ppm(orange), and0.4
ppm (red).D,mapping of residues exhibiting significant resonance perturbations upon addition of the H3K4me3 ligand onto the surface of the NMR structure
of the ligand-free ING3 PHD finger (PDB code 1X4I). The residues in the binding pocket are colored red, orange, and yellow depending on themagnitude of the
chemical shift change upon ligand addition as in C.
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of secondary structures, including the double-stranded antipa-
rallel -sheet that forms the core of the PHD domain (Fig. 3B).
The structural integrity and secondary structural elements of
the protein were maintained well throughout the simulations,
which was ascertained by the coordination geometries mea-
sured between the Zn2 cations and interacting residue atoms,
and the secondary structure analysis (data not shown).
The MD simulation data were processed using molecular
mechanics/Poisson-Boltzmann surface area (MM/PBSA) and
Generalized Born surface area (MM/GBSA) formalisms (45),
utilizing the normal-mode analysis to obtain rotational, trans-
lational, and vibrational entropy (46). The resulting binding
free-energy values (G) and their components are summarized
for the histone peptides in Table 2. The relative energies cal-
culated for the histone peptides (H3K4me3, H3K4me2,
H3K4me1, H3 unmodified, and H4 unmodified) show good
agreement with the experimental NMR, ITC, and Trp fluores-
cence binding data. The most favorable binding energy was
observed for the H3K4me3 peptide, followed by the H3K4me2,
H3K4me1, andH3unmodified peptides, respectively. The non-
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D
W47
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FIGURE 3.Characterizationof specific ING3PHD finger-histone ligand interactions.A,domain architecture of the full-length human ING3proteinwith the
sequence alignment of the PHD finger domains of ING1–5. Residues 1–418 of human ING3 are shownwith theN-terminal leucine zipper-like domain (LZL) and
novel conserved region (NCR), as well as the nuclear localization signal (NLS) and C-terminal PHD. Sequence alignment of the PHD finger domains of ING1–5
were aligned to the ING3PHD construct used in this study (residues 4–57, corresponding to residues 360–409 in full-length ING3). The conserved Cys4-His-Cys3
PHD fingermotif residues involved in zinc coordination are highlighted in blue; the aromatic cage residues are highlighted in orange, and residuesmutated in
this study are colored in red. B, time-averaged structure of the ING3 PHD finger in complex with the H3K4me3 peptide ligand obtained using MD simulation.
PyMOL (32) was used to depict the ING3 PHD finger, shown in green, and the peptide ligand is colored in blue. Hydrogen bonds and salt bridges are indicated
by red dotted lines. C, structural alignment of the ING1–5 PHD finger proteins in complex with the H3K4me3 histone peptide. Structures of the ING PHD
complexes were taken from the Protein Data Bank and aligned in PyMOL (32). The structures include ING1 (2QIC, orange), ING2 (2G6Q, blue), ING3 (MD
simulation,green), ING4 (2PNX,magenta), and ING5 (3C6W, yellow).D, surface representationof the time-averaged structureof the ING3PHD-H3K4me3complex
from theMD simulation showing specific pointmutations introduced into the binding pocket by site-directedmutagenesis, with theH3K4me3 histone ligand
in the binding pocket shown in blue. E, circular dichroism spectra in the far-UV region of the ING3 PHD finger wild-type and mutant proteins. The percent
-helical content of each protein is listed in the inset.
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binding histone H4 unmodified peptide correctly generated a
relatively weak binding energy. The trajectories from each of
10-ns MD simulations (a total of 5000 snapshots or frames,
each representing a 2-ps time interval) were analyzed for the
presence of H-bond interactions between the ING3PHD protein
and the histone peptide residues. The strength and geometries
were quantitatively described in terms of bond length and
donor-H-acceptor bond angles as well as the longevities of the
H-bond as % of frames (5000 frames represent 100%), in which
the bonds were seen.
In the time-averaged structure of the ING3PHD-H3K4me3
complex from the MD simulation (Fig. 3B and supplemental
data file ING3PHD-H3K4me3-MDsimulation.pdb), the his-
tone peptide binds to the PHD domain forming a third antipa-
rallel -strand that pairs with the central -sheet core
described above (Fig. 3C). Themost common interactions seen
with all of the methylated histone H3 peptides (mono-, di-, and
tri-methylated and non-substituted lysines) and the ING3PHD
are intra--strand backbone contacts between the Lys-4 resi-
dues of the histone peptides and Met-19 in ING3PHD. Table 3
summarizes the hydrogen bond interactions seen at least 40%
of the time throughout the production phase ofMD simulation.
The average bond lengths and bond angles of theseH-bonds are
also summarized inTable 3. For example, theH-bonds between
backbone atoms ofMet-19 andGly-21 of ING3 and the histone
H3 peptide residues Lys-4 and Arg-2 occur for nearly the entire
10-ns trajectory of all MD simulations (92.9–99.9%). These
conserved intra--sheet hydrogen bonds facilitate the impor-
TABLE 2
ING3-histone peptides binding energies by free energy calculations
No. Peptide
Binding free energies and its components (kcal/mol)
Sa
MM/GBSAbb MM/PBSAbb
GBSA G Gc PBSA G Gc
kcal/mol
1 H3K4me3 42.358 70.332 27.975 65.248 22.890
2 H3K4me2 40.958 62.682 21.724 61.206 20.249
3 H3K4me1 42.956 60.704 17.749 61.068 18.112
4 H3K4me0 38.316 56.285 17.970 54.131 15.816
5 H4-unmodified 39.460 42.744 3.285 43.705 4.245
a Rotational, translational, and vibrational entropy was from normal mode analysis.
bMolecular Mechanics/Generalized Born Surface Area and Molecular Mechanics/Poisson-Boltzmann Surface Area Methods are described in Ref. 45.
c Difference between GBSA or PBSA G and S is shown.
TABLE 3
Hydrogen bond interactions between the ING3 PHD finger and histone peptides fromMD simulations
Histone peptide
Interacting residues
% present Average bond length Average bond anglePeptide ING3
Å °
H3K4me3 K4me3@N-H Met-19@O 99.96 2.95 159.85
K4me3@O Met-19@N-H 98.44 2.93 153.88
Arg-8@O Gly-17@N-H 99.46 2.96 159.71
Thr-6@N-H Gly-17@O 84.08 3.09 150.95
Arg-2@O Gly-21@N-H 99.10 2.99 155.59
Arg-2@NH2-HH21 Cys-22@O 69.38 3.02 141.96
Arg-2@NH2-HH22 Glu-30@OE2 50.86 2.89 150.60
Arg-2@NH1-HH11 Glu-30@OE2 50.64 2.93 148.85
Arg-2@NH1-HH12 Glu-30@OE1 46.54 2.86 152.13
Arg-8@NE-HE Ser-15@O 85.44 2.97 145.35
H3K4me2 K4me2@N-H Met-19@O 99.86 3.01 157.29
K4me2@O Met-19@N-H 97.06 2.94 150.87
Arg-8@O Gly-17@N-H 99.46 2.95 159.54
Arg-2@O Gly-21@N-H 99.34 2.98 154.54
Arg-2@NE-HE Asp-23@OD1 77.36 2.88 149.88
Arg-2@NH2-HH21 Asp-23@OD1 77.10 2.84 148.06
Thr-6@N-H Gly-17@O 78.76 2.93 151.51
H3K4me1 K4me2@N-H Met-19@O 99.88 2.98 157.16
K4me2@O Met-19@N-H 98.24 2.93 154.48
Arg-2@NE-HE Asp-23@OD1 72.02 2.86 150.64
Arg-2@O Gly-21@N-H 99.22 3.02 155.08
Arg-2@NH1-HH12 Glu-30@OE1 77.96 2.83 153.52
Arg-2@NH2-HH22 Glu-30@OE1 76.02 2.98 143.27
Arg-2@NH2-HH21 Asp-23@OD1 64.78 2.94 142.04
Arg-8@O Gly-17@N-H 58.44 3.04 159.48
Thr-6@N-H Gly-17@O 56.62 3.01 149.52
H3 unmodified Lys-4@NH Met-19@O 99.36 2.95 155.64
Lys-4@O Met-19@N-H 92.94 2.98 155.10
Arg-2@O Gly-21@N-H 98.50 2.99 152.15
Arg-8@O Gly-17@N-H 97.54 2.99 158.64
Arg-2@NE-HE Asp-23@OD1 72.08 2.89 149.81
Arg-2@NH2-HH21 Asp-23@OD1 69.96 2.86 147.77
Thr-6@N-H Gly-17@O 59.72 3.12 151.08
H4 unmodified Gly-3@N-H Ser-6@O 83.62 3.06 151.85
Gly-4@O Tyr-8@N-H 49.70 3.21 142.92
Gly-3@N-H Ser-3@O 42.78 2.96 151.46
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tant cation- interactions exhibited by the methylated histone
peptides and residues Trp-31 and Tyr-8 in the ING3PHD.
As in other ING PHD finger proteins, the H3K4me3 peptide
binds in a deep and extensive pocket that consists of two large
grooves connected by a narrow channel (37, 40). The tri-meth-
ylated Lys-4 side chain fits into one groove containing residues
Trp-31, Tyr-8, and Ser-15 identified from the NMR chemical
shift perturbation and MD simulation data (Figs. 2D and 3B).
Fig. 3B, highlights the hydrogen bond interactions observed
between amino acid side chains of the histone H3K4me3 pep-
tide and the ING3PHD. For instance, the side chain amino group
of Arg-2 in the histone peptidemakes a constant H-bond inter-
action with the side chain carboxylic group of Glu-30 of
ING3PHD, which was observed throughout the entire 10-ns
simulation time (Table 3). Table 3 includes the details of the
Arg-2 interaction from the MD simulations and also reveals
several strong H-bond interactions made by the Thr-6 and
Arg-8 residues of H3K4me3.
Molecular Mechanism of Methyl-lysine Coordination—Our
NMR chemical shift perturbation experiments and MD simu-
lation data of the ING3PHD-H3K4me3 ligand complex suggest
that several amino acids in the ING3PHD binding pocket are
crucial for histone recognition and coordination of the tri-
methylated lysine moiety. To further investigate the contribu-
tion of specific amino acids to ligand binding, we carried out
site-directed mutagenesis on ING3PHD residues and measured
their effect on ligand binding affinity with ITC experiments.
We selected ING3PHD residues Trp-47 , Ser-15, Pro-43, Tyr-8,
and Trp-31 formutagenesis to alanine because of their proxim-
ity to the binding pocket and/or direct involvement in
H3K4me3 coordination (Fig. 3D). As shown in Table 4 and Fig.
4, theW31Amutation had the largest effect on histone peptide
binding, resulting in no recognition of this ligand. This is likely
due to the importance of residue Trp-31 in formation of the
aromatic cage in the ING3PHD as well as cation- interactions
between the side chain of this residue and the trimethylammo-
nium group of Lys-4. The W47A and Y8A mutations reduced
the ING3PHD binding affinity from 0.93 M for theWT protein
to 48 and 46 M in the mutant proteins, respectively. This
observation is not surprising because Trp-47 forms the bottom
of theArg-2 binding pocket andTyr-8 comprises one side of the
aromatic cage around Lys-4. Both Trp-47 and Tyr-8 likely con-
tribute to the structural features of the binding pocket and
make important hydrophobic interactions with the histone
ligands. Additionally, mutation of Trp-47 to alanine resulted in
significant structural changes in the ING3PHD causing a large
increase in the -helical content of the protein as observed by
circular dichroism (Fig. 3E). These results indicate that Trp-47
also plays a role in the hydrophobic packing and folding of the
ING3 PHD finger motif. Mutation of ING3PHD residues Pro-43
and Ser-15 had a less dramatic effect, resulting in a 2–3-fold
drop in binding affinity for the H3K4me3 histone ligand (Table
4). Pro-43 was previously shown to be important for the coor-
dination of Ala-1 of the histone H3 peptide for ING5PHD (37);
however, there were no hydrogen bond interactions observed
in any of ourMD simulations (Table 3). Interestingly, the P43A
mutation did change the -helical content of the ING3PHD
from 55 to 80%, indicating it does play an important structural
role in protein folding/packing. Residue Ser-15 is highly con-
served in all ING PHD finger proteins andmakes up one side of
the Lys-4 binding pocket. However, mutation of Ser-15 to ala-
nine only produced a 2-fold drop in ligand binding affinity. The
trajectory analysis of the MD data indicates that in the
ING3PHD-H3K4me3 complex, Ser-15 does make hydrogen
bond contacts to the Arg-8 side chain in the histone peptide
over 85%of the simulation time (Table 3), but themodest 2-fold
drop in binding affinity observed by ITC suggests that this
interaction is less critical for histone ligand coordination than
Tyr-8 and Trp-47 (Table 4). This is corroborated by only mod-
erate chemical shift changes of the Ser-15 residue upon addi-
tion of the H3K4me3 peptide in NMR titration experiments
(Fig. 2C).
Because the ING3 protein is a known tumor suppressor that
is down-regulated in multiple cancers (8, 47, 48), we searched
the cBioPortal for Cancer Genomics to see whether any muta-
tions in the PHD finger of ING3 have been reported in cancer
patients (33, 49). Our search uncovered three mutations in the
ING3PHD, which include a frameshift insert at Cys-376 (Cys-22
in our MD simulation structure) found in cutaneous skin mel-
anoma, a missense mutation H387P (His-33) associated with
bladder carcinoma, and a missense mutation at D380H (Asp-
26) found in head and neck carcinoma. Because the Cys-22 and
His-33 residues are important for zinc ion coordination in the
PHD finger motif, and their mutation would likely result in
unfolding of the PHD domain, we focused on the effect of the
D26H mutation on histone recognition by the ING3PHD. As
with the S15A and P43A mutations, the D26H mutation
resulted in a slightly weaker binding affinity for the
H3K4me3 histone peptide as compared with the WT
ING3PHD with a KD of 1.93  0.26 M (Table 4 and Fig. 4F).
Interestingly, according to our circular dichroism analysis,
this mutation increases the -helical content slightly, from
56% in the WT ING3PHD to 60% in the ING3PHD-D26H pro-
tein (Fig. 3E and Table 5). As seen in Fig. 3D, residue Asp-26
(highlighted in cyan) is located peripheral to the histone
binding pocket, so it is not surprising that this mutation has
only a minor effect on histone recognition.
Interaction of ING3 with the TIP60 Complex—As described
above, the ING3 protein is a functional subunit of the TIP60
HAT, and recognition of methylated histones by the ING3PHD
is thought to recruit this multisubunit chromatin remodeling
complex to histones to regulate gene expression (17). To deter-
mine whether ING3 mutants defective in H3K4me3 binding
were retained within the TIP60 HAT complex (17, 19), FLAG-
tagged full-length (residues 1–418) ING3WT, ING3Y362A, and
ING3W385A forms were expressed in highly transfectable
TABLE 4
Binding of the H3K4me3 peptide by ING3 PHDmutants by ITC
Mutant ITC KD
M
ING3 PHD S15A 1.50 0.01
ING3 PHD D26H 1.93 0.26
ING3 PHD P43A 2.45 0.27
ING3 PHD Y8A 46 2.99
ING3 PHDW47A 48.31 0.23
ING3 PHDW31A No binding
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COS-7 monkey cells. Then, anti-FLAG immunoprecipitates
were analyzed by immunoblotting with anti-TIP60 and anti-
TRRAP antibodies. As observed with ING2 (14, 50) and ING4
(13), the defective H3K4me3-binding mutants, ING3Y362A and
ING3W385A proteins do associate with the TIP60 and TRRAP
subunits of the HAT complex (Fig. 5A).
The exogenous expression of ING proteins generally poten-
tiates DNA damage responses and induces apoptosis (13). To
determine whether the association with H3K4me3 is required
for ING3 to induce apoptosis, human mammary carcinoma
MCF7 cells were transduced with the ING3WT, ING3Y362A, or
ING3W385A proteins (which correspond to residues Tyr-8 and
Trp-31 highlighted in the time-averaged structure of the
ING3PHD-H3K4me3 complex from the MD simulation, Fig.
3D), and DNA damage was induced by treating the cells with
doxorubicin. Expression of ING3WT affected the cell cycle, and
after treatment with doxorubicin we observed a decreased per-
centage of cells in both G1 and S phase (Fig. 5B). Interestingly,
P43A
KD = 2.45 ± 0.27 μM
S15A
KD = 1.50 ± 0.01 μM
W47A
KD = 48.31 ± 0.23 μM
W31A
KD = no binding
A B C
D E
Y8A
KD = 46.0 ± 3.0 μM 
F
D26H
KD = 1.93 ± 0.26 μM
FIGURE 4. ITC measurements of interactions between mutant ING3 PHD finger proteins and the H3K4me3 histone tail ligand. A–F, exothermic ITC
enthalpy plots for the binding of the ING3 PHD finger mutant proteins to the H3(1–12)K4me3 peptide. The inset lists the measured binding constants.
TABLE 5
Analysis of ING3 PHD finger proteins by circular dichroism
ING3 PHD protein -Helix -Strand
% %
WT 55.81 1.85
S15A 57.57 0.99
D26H 60.31 0.81
P43A 80.5 0.06
Y8A 50.58 2.57
W47A 90.16 0.04
W31A 32.08 5.44
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FIGURE 5. ING3mutant proteins form a complex with TIP60, and the ING3PHD-H3K4me3 association is required for ING3-induced DNA damage-
dependent cell death. A, full-length ING3 mutant proteins defective in H3K4me3 binding were retained within the TIP60 complex. COS-7 cells were
transfected with pCMV-3FLAG-ING3 wild-type (WT), Y362A (Y362A), or W385A (W385A) vectors for 72 h. Exogenous ING3 was immunoprecipitated
with a FLAG antibody followed by immunoblotting. Empty pCMV-3FLAG vector was used as a control in lane C. B and C, MCF7 cells were stably
transduced with FLAG-ING3-expressing retroviral particles as indicated for 72 h, and for the final 20 h cells were treated with 400 ng/ml doxorubicin
(doxo). Subsequently, cell cycle status was determined by flow cytometry analysis of propidium iodide staining. Distribution of cells in cell cycle phases
(B) and percentage of cells in sub-G1 phase (C) were determined. Data were plotted as the mean  S.E. of three independent experiments; statistical
analysis was undertaken with t test, and the * indicates p	 0.05. D,MCF7 cells were transduced with retroviral particles as in B for 72 h, and for the final
20 h the cells were treated with 400 ng/ml doxorubicin (doxo). Subsequently, the percentage of apoptotic cells was determined by flow cytometry
detection of annexin V-positive cells. Data were plotted as the mean S.E. of three independent experiments, and statistical analysis was undertaken
with t test.
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doxorubicin induced an increase in the sub-G1 population in
the presence of ING3WT (p value 0.005), but not with the
ING3Y362A or ING3W385A forms (Fig. 5, B and C), suggesting
that the association of ING3 with H3K4me3 is required for the
full-length ING3 protein to regulate apoptosis. Indeed, in par-
allel experiments, addition of doxorubicin induced an increase
in annexin V staining in ING3WT-expressing cells (p value
0.006) but not in ING3Y362A- or ING3W385A-expressing cells (p
values of 0.2 and 0.3, respectively) (Fig. 5D). These results are
consistent with functional studies on other ING proteins,
which suggest that H3K4me3 recognition tethers ING3 to its
histone ligands and stimulates its biological activity (13, 14, 27,
37, 39).
Discussion
Our results demonstrate that the ING3 PHD finger prefer-
entially binds to histone H3K4me3 over H3K4me2, H3K4me1,
and the unmodified histone H3. Furthermore, this study con-
firms that selection of tri-methylated histones by the ING3PHD
is a conserved function of the PHD finger domains in all ING
family proteins, including ING1, ING2, ING4, and ING5,which
underscores its importance in directing their biological func-
tion (13, 14, 27, 37, 39). The molecular mechanism of histone
recognition by the ING3 PHD finger was evaluated using
experimentally observed interactions between the ING3PHD
and the histone H3K4me3 ligand with a combination of
NMR chemical shift perturbation experiments and muta-
tional analysis. The experimental results are supported by
data obtained from the time-averaged structure of the
ING3PHD-H3K4me3 complex using MD simulation. The
Trp-31 and Tyr-8 residues help form an aromatic cage in
the ING3PHD binding pocket, and they directly coordinate
the tri-methylated lysine 4 in the histone H3 ligand. To rec-
ognize and specifically select for histone H3, ING3PHD also
makes important contacts using residues Trp-47, Asp-23,
and Cys-22 to create a secondary binding pocket and to form
hydrogen bonds to Arg-2 in the histone peptide. As observed
with other PHD fingers, the two grooves in the ING3PHD
H3K4me3 binding pocket that coordinate Lys-4 and Arg-2
are separated by a narrow channel, which precludes binding
of histone peptides with a large side chain at position 3. MD
simulations revealed that the trimethylammonium group of
Lys-4 is largely coordinated by hydrophobic and cation-
interactions with residues Tyr-8 and Trp-31 in the ING3PHD
binding pocket. Additionally, mutation of Tyr-8 and Trp-31
prevented histone binding in our ITC assays. These results
demonstrate that formation of the ING3-H3K4me3 complex
is driven by a combination of hydrogen bonding, comple-
mentary surface interactions, and hydrophobic contacts.
We used the time-averaged structure of the ING3PHD-
H3K4me3 complex generated by MD simulation to compare
coordination of the histone H3K4me3 peptide by ING3PHD
with x-ray crystal structures of the other ING PHD fingers
bound to H3K4me3. Superposition of the ING3PHD-H3K4me3
MD simulation onto the ING1PHD, ING2PHD, ING4PHD, and
ING5PHD structures revealed that the overall structural fold
and the histone binding mechanism among these PHD fingers
is highly conserved (Fig. 3C). The time-averaged structure of
the ING3PHD-H3K4me3 complex from the MD simulation is
most closely related to the x-ray crystal structure of ING1PHD
(PDB code 2QIC, r.m.s.d. of 0.86 Å over 53 C atoms), followed
by ING2PHD (PDB code 2G6Q, r.m.s.d. of 0.87 Å), 
NG5PHD
(PDB code 3C6W, r.m.s.d. 1.094 Å), and ING4PHD (PDB code
2PNX, r.m.s.d. 1.098 Å). Interestingly, our ligand-bound time-
averaged MD simulation structure of the ING3PHD-H3K4me3
complex superimposes more closely with the other ligand-
bound ING PHD finger structures than it does with the ligand-
free NMR structure of ING3PHD (PDB code 1X4I) (r.m.s.d.,
range from 1.3 o 2.0 Å over the C atoms) (40). As seen in Fig.
3C, the orientation of the H3K4me3 histone peptide in the
binding pocket is conserved among all five of the INGPHD-
H3K4me3 structures. In addition, the same specific molecular
interactions observed in our MD simulation of ING3PHD-
H3K4me3 complex are also found in the other INGPHD-
H3K4me3 structures, revealing that all of the ING PHD fingers
use a conserved binding mode for histone ligand recognition.
For example, in the time-averaged structure of the ING3PHD-
H3K4me3 complex from the MD simulation, the semi-aro-
matic cage is formed around the trimethylammonium group of
Lys-4, in which Trp-31 and Tyr-8make cation-, hydrophobic,
and van der Waals contacts with this group. Residues Met-19
and Ser-15 compose the remainder of the hydrophobic
cage, and all four of these residues are conserved in the PHD
finger binding pockets of ING1–5 (Fig. 3A) (40). Additionally,
the coordination of Arg-2 in the H3K4me3 histone peptide is
similar among the ING PHD finger proteins with hydrogen
bond contacts between the side chains of Glu-30, Asp-23, and
the backbone carbonyl of Cys-22 in ING3PHD, to the side chain
amino groups of Arg-2 (Fig. 3B). The same interactions are
observed between residues Glu-234, Asp-227, and Cys-226 of
the ING1 PHD finger and the Arg-2 side chain in theH3K4me3
histone peptide (39), and this bonding pattern is also seen in the
ING2, ING4, and ING5 PHD finger proteins (13, 27, 37). Thus,
this structural comparison of the molecular recognition of
H3K4me3by the ING3PHD fingerwith other INGPHDproteins
reveals that the mechanism of histone ligand binding is univer-
sally conserved within the ING protein family.
Finally, experiments with the full-length ING3 protein
revealed that PHD finger mutations that inhibit H3K4me3
binding do not have an effect on the presence of ING3 in the
TIP60 HAT complex, but they do prevent ING3 from up-reg-
ulating DNA damage-induced cell death. A recent study also
showed that the chromodomain inTIP60 recognizesH3K9me3
and stimulates the acetylation of the ataxia telangiectasia
mutated protein kinase inDNAdouble strand break repair (20).
The recruitment of large enzymatic complexes involved in
chromatin remodeling is often carried out by epigenetic
“reader” domains that recognize post-translational modifica-
tions on the nucleosomes (37, 51–54). These data indicate that
recognition of H3K4me3 by the ING3 PHD is necessary to tar-
get the TIP60 complex acetyltransferase activity to up-regulate
apoptosis. Collectively, the structural and functional informa-
tion presented here will be essential for further study of the
biological activity of ING3 in the TIP60 HAT complex and the
role of the ING3 PHD finger domain in epigenetic signaling by
this complex.
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Experimental Procedures
ING3 PHD Plasmid Construction—The ING3 PHD finger
region (residues 360–409) was amplified using PCR and
cloned into the pDEST15 vector encoding an N-terminal
glutathione transferase (GST) tag using the Gateway cloning
technology (Invitrogen) as described previously (55).
ING3PHD proteins with single mutations at W31A, W47A,
S15A, P43A, Y8A, and D26H were generated using the
QuikChange mutagenesis procedure (Stratagene) as de-
scribed previously (56). The DNA sequence for wild-type
and mutant proteins was verified at the University of Ver-
mont DNA facility, and the plasmids were transformed into
in Escherichia coli RosettaTM 2(DE3)pLysS competent cells
(Novagen) for protein expression.
ING3 PHD Finger Expression and Purification—E. coli cells
containing the wild-type GST-tagged ING3PHD were grown
in Terrific Broth (TB) or in 15NH4Cl-supplemented or
15NH4Cl/13C6 D-glucose-supplemented minimal media. The
cultures were grown at 37 °C to an A600 of 1, induced with
0.25 mM isopropyl -D-1-thiogalactopyranoside (IPTG), and
incubated for an additional 16 h at 20 °C. Recombinant pro-
tein was purified by sonicating the harvested cell pellet
resuspended in 200 ml of lysis buffer (50 mM Tris-HCl, pH
7.5, 150 mM NaCl, 0.05% Nonidet P-40, and 1 mM DTT),
containing 0.1 mg/ml lysozyme, 50 units of DNase I (Thermo
Scientific), and 1 tablet of Pierce Protease Inhibitor mixture
(Thermo Scientific). After centrifugation at 10,000 rpm for
10 min, the cell supernatant was added to 12.5 ml of gluta-
thione-agarose resin beads (Thermo Scientific) and incu-
bated on ice (4 °C) for 2 h while agitating. The beads were
added to a 25-ml Econo-Column chromatography column
(Bio-Rad) and washed with three column volumes of wash
buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 1 mM
DTT). The GST tag was cleaved overnight at 4 °C by addition
of PreScission Protease (GE Healthcare), and the ING3 PHD
finger was eluted in wash buffer and concentrated to about
3-ml total volume. Protein concentration was determined by
absorbance measurement and the A280 extinction coefficient
of ING3PHD (16960 M1 cm1). The purity of the ING3 PHD
finger was verified by SDS-polyacrylamide gels stained with
GelCode Blue Safe protein stain (Thermo Scientific).
TryptophanFluorescenceSpectroscopy—Tryptophan fluores-
cence spectra of samples in tryptophan fluorescence buffer (100
mM NaPO4, pH 7.5, 150 mM NaCl, and 1 mM DTT) were col-
lected at 25 °C using a Cary Eclipse fluorescence spectrometer
(Varian). The samples contained 10 M ING3 PHD finger pro-
tein and progressively increasing concentrations of histone H3
and H4 peptides. The 12- and 14-mer unlabeled histone tail
peptides with an amidated C terminus and specificmethylation
modifications (H3K4me3, H3K4me2, H3K4me1, H3 unmodi-
fied, andH4 unmodified) were synthesized by the Peptide Core
Facility at the University of Colorado at Denver. After excita-
tion at 295 nm, emission spectra were recorded between 305
and 405 nm with 0.5-nm increments and at a 1-s integration
time, averaging over three scans. Each titration experiment was
repeated three times, and the averageKD values were calculated
using quadratic Equation 1,
Fi 
 FsXT  YT  KD  XT  YT  KD2  4XTYT
2XT
(Eq. 1)
where Fi is the fluorescence change; Fs is the fluorescence
change at saturation of XT (the total protein concentration);
and YT is the peptide concentration.
Isothermal Titration Calorimetry—ITC measurements were
recorded at 5 °C using a MicroCal iTC200 (GE Healthcare) as
described previously (55). The wild-type and mutant ING3PHD
proteins and histone peptide samples were prepared in a 20mM
NaH2PO4, pH 7.0, and 150 mM NaCl ITC buffer by dialysis for
24–48 h. Titration experiments were set up for optimal heat of
binding reactions by using 100–200M ING3PHD in the sample
cell, and between 1 and 5 mM histone peptide in the injection
syringe. Control experiments were performed under identical
conditions to determine the heat of dilution of the titrant peptides
into the experimental buffer. This was subtracted from the exper-
imental data as part of data analysis. Data were analyzed using the
software ORIGIN 7.0 (OriginLab Corp.). All experiments where
bindingoccurredwereperformed in triplicate,whereas non-bind-
ing experiments were performed in duplicate.
HSQC-NMR—Chemical shift perturbation experiments
were conducted using 0.5 mM uniformly 15N-labeled ING3
PHD finger in buffer containing 20 mM Tris-HCl, pH 6.8, 150
mMNaCl, 10mMDTT, and 10%D2O. Titrationmixtures of the
ING3PHD protein and each of the modified histone peptides
were prepared at concentration ratios of 1:0, 1:0.13, 1:0.26,
1:0.52, 1:1.3, and 1:2.61 in a volume of 35 l. These mixtures
were then transferred into 1.7-mm NMR tubes (Bruker).
Two-dimensional 15NHSQC (heteronuclear single quantum
coherence) experiments for all samples were run at 25 °C on a
600 MHz Bruker AVANCE III spectrometer equipped with a
z-gradient 1.7-mm TCI probe at the National Magnetic Reso-
nance Facility atMadison (NMRFAM) using the NMRBot soft-
ware (57). The NMR data were collected with 1024 128 com-
plex data points along the 1H and 15N dimensions, with
acquisition times of 104 and 81 ms, respectively, using eight
scans per free induction decay. Normalized chemical shift
changes were calculated using Equation 2,
	  	H2 	N/52 (Eq. 2)
where 	H and 	N are the proton and nitrogen change in
chemical shift in ppm, respectively.
KD values were calculated by a nonlinear least squares anal-
ysis in KaleidaGraph using Equation 3,
	  	max
[L] [P] KD [L] [P] KD2 4[P][L]
2[P]
(Eq. 3)
where [L] is the concentration of the peptide; [P] is the concen-
tration of the protein;	 is the observed chemical shift change,
and 	max is the normalized chemical shift change at
saturation.
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To obtain the backbone resonance assignments, 1 mM of the
15N,13C double-labeled ING3 PHD finger was prepared in
buffer containing 20 mM Tris-HCl, pH 6.8, 150 mM NaCl, 10
mM DTT, and 10% D2O. The Agilent version of ADAPT-NMR
(Assignment-directed Data collection Algorithm utilizing a
Probabilistic Toolkit in NMR) was used to optimize simultane-
ous fast data collection and fully automated NMR backbone
assignments. In addition to a two-dimensional 1H-15N HSQC
spectrum, ADAPT-NMR recorded six three-dimensional spec-
tra as two-dimensional orthogonal and tilted planes at optimal
projection angles as follows: HNCO,HN(CA)CO, HN(CO)CA,
HNCA, CBCA(CO)NH, and HN(CA)CB (58). These experi-
ments were collected at 25 °C on a 600 MHz Varian VNMRS
spectrometer equipped with a z-gradient 5mm cryogenic
probe. All two-dimensional planes were processed automati-
cally by ADAPT-NMR with NMRpipe software (59). After less
than 1 day, ADAPT-NMR was able to assign all backbone
amides (100%). These fully automated assignments were visu-
alized, validated, and further refined by using the ADAPT-
NMREnhancer package (60). This inspection led to the correc-
tion of backbone assignments for two residues.
MDSimulations—TheMD simulations were used to investi-
gate the molecular interactions of the ING3PHD with histone
peptide ligands. The published NMR solution structure of the
ING3protein (PDBcode 1X4I)was taken from the ProteinData
Bank (61). The 1X4I structure wasmodified with Biopolymer, a
structure preparation tool in the SybylX2.1 suite; theN- and the
C-terminal residues were capped with N-acetyl and N-methyl-
amide groups; and protonation types were set for His (
-proto-
nated), Glu (negatively charged), and Lys (positively charged)
residues. The Cys and His residues making tetrahedral coordi-
nation geometrywith structural zinc atomswere treated as spe-
cial residues in their anionic forms as follows: CY1 residue in
zinc-CCCC, CY2, and HIN in zinc-CCCH coordination struc-
tures, respectively. The force field parameters for these residues
were adopted from ZAFF (62). The side chains of residues Cys-
21, Cys-26, Cys-48, and Cys-51 coordinate Zn1 in zinc-CCCC
fashion, and Cys-8, Cys-10, Cys-35, and the His-32 coordinate
Zn2 in zinc-CCCH fashion; both exhibit tetrahedral geometry.
The starting structures forMD simulations were obtained by
flexible protein-peptide docking using the Rosetta FlexPep-
Dock (41, 42) docking program. The docking protocol incorpo-
rates iterative cycles of optimization and energy minimization
that include full flexibility and rigid body orientation for the
peptide backbone, as well as side chain flexibility for both the
peptide and the receptor protein. The resulting FlexPepDock
complexes were ranked based on the Rosetta full-atom energy
function (Rosetta score 12) available within the Rosetta model-
ing framework (43). The complexes with the highest scores
were used as input for the MD simulations.
The FlexPepDock program requires the approximate initial
conformation of peptide close to its putative binding pocket.
For the H3 peptides, the x-ray crystal structures of ING4 (PDB
code 2PNX) and ING5 (PDB code 3C6W), in which the
H3K4Me3 peptide is bound to the respective proteins, were
used as starting templates. The ING4PHD-H3K4me3 and
ING5PHD-H3K4me3 structures were aligned with the apo-
ING3 structures (PDB code 1X4I) based on homology, using
the Biopolymer module in Sybyl-X2.1. No structures are avail-
able for ING PHD fingers bound to the unmodified histone H4
peptide. Hence, the starting conformation was obtained by
docking the unmodified H4 peptide to ING3PHD using the Hex
docking program through its webserver (accessed on June 1,
2014) (44). The Hex docking algorithm is based on spherical
polar correlations of protein surface shape and electrostatic
representations. The initial constraints given to the program
were the putative binding residues of the protein observed in
ourNMR titration studies. The three lowest energy poses of the
unmodified histone H4 peptide obtained from the Hex pro-
gram were fed into the FlexPepDock server to ascertain the
binding conformations, and the best pose with the highest
Rosetta 12 score was selected for MD simulation, as described
above for the H3 peptides.
The MD simulations were performed using the Amber 14
package (63) under isothermal/isobaric (NPT) conditions with
Amber ff14SB force field (64) for protein and peptide mole-
cules. The force field parameters for methylated lysine (mono-,
di-, and tri-methylated) were obtained by following the stan-
dard procedure used in the AMBER force field development
utilizing the Mulliken charges calculated as shown previously
(55). The backbone torsion parameters are the same as those of
the natural lysine residue in the AMBER ff14SB force field.
To prepare the ING3PHD structure for MD simulations, the
Leap program from Antechamber tools, AmberTools 14 suite
(63, 65), was used to generate the parameter/topology (prmtop)
and input coordinate (inpcrd) files. The net charge of the pro-
tein-peptide complexes varied from3 to4 depending upon
the overall charge of the peptide, andwas neutralized by adding
Cl ions at positions of high positive electron potential around
the complexes. The system was immersed in a truncated octa-
hedral box of pre-equilibrated TIP3P water molecules (66) in
the way that no atoms in the protein-ligand complexes were
closer than 16 Å to any of the sides of the water box. The coun-
ter ions and solvent molecules were briefly minimized (2500
steps) to remove any bad contacts with the complexes, whereby
the protein and peptides were position-restrained using force
constant of 100 kcal/(molÅ2), followed by another 2500-step
minimization of the whole solvated complex.
To allow the readjustment of solventmolecules to the poten-
tial field of the protein-peptide complex, the solvent equilibra-
tion step was performed in three stages. The details of this
equilibration step have been described previously (55). The
production phase with the entire system was carried out under
isothermal/isobaric conditions for 10 ns. The SHAKE algo-
rithm (67) was used to constrain bonds involving hydrogen,
allowing time steps of 2 fs, for a total of 5,000,000 steps. The
trajectory file waswritten for every 1000 steps (2 ps) resulting in
5000 frames. The cutoff for non-bonded interactions was set to
12Å in all steps. H-bond interaction analysis was carried out on
the 5000 snapshots from the entire 10-ns production phase
using the cpptraj program in the AmberTools 14 suite (63, 65),
with the cutoff values for distance (3.2 Å) and angle (135°). The
pairwise interactions were monitored between the ING3PHD-
binding site residues (Tyr-8, Gln-13, Val-14, Ser-15, Tyr-16,
Gly-17, Glu-18, Met-19, Val-20, Gly-21, Cys-22, Asp-23, Gln-
25, Glu-30, and Trp-31) and all histone peptide residues.
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To calculate the free energy of binding for each peptide, we
used the Molecular Mechanics/Poisson Boltzmann Surface
Area (MM/PBSA) method (45), which combines the molecular
mechanical energies with the continuum solvent approaches.
The molecular mechanical energies represent the internal
(bond, angle, and dihedral) energy and van derWaals and elec-
trostatic interactions. The nonpolar contribution to the solva-
tion free energy is determined with solvent-accessible surface
area-dependent terms. The method separates nonpolar contri-
bution into two terms as follows: the attractive (dispersion) and
repulsive (cavity) interactions. The estimates of vibrational
entropies were made using the frequencies from the normal
mode analysis with the nmode or NAB module from Amber.
The calculations were done using the recently published
MMPBSA.py program (46) from Amber Suite.
Full-length ING Plasmids—The cDNA of human ING3 was
cloned by PCR (Platinum PCR SuperMix High Fidelity (Invit-
rogen; catalog no. 12532-016) with fwd 5-ggccAGATCTttg-
tacctagaagactatctgga-3 and rev 5-aggacTCGAGttatttgtgtct-
gctgcctct-3 primers) on reverse-transcribed (SuperScript
VILO Master Mix; Invitrogen; catalog no. 11755-050) total
RNA isolated (TRIzol; Invitrogen; catalog no. 15596-026) from
breast carcinoma MCF7 cells. The PCR product was gel-puri-
fied, digested with BglII (New England Biolabs) and XhoI (New
England Biolabs), and inserted in pCMV 3FLAG (Stratagene
pCMV-3Tag-1A) or pMF retroviral vector (68). The Y362A
andW385A H3K4me3-binding defective mutants were gener-
ated by site-directed mutagenesis using degenerate primers
(Y362A fwd 5-ccaaatgaacctcgaGCctgcatttgtaatcag-3 and
Y362A rev 5-ctgattacaaatgcagGCtcgaggttcatttgg-3; W385A
fwd 5-gattgccctatagaaGCgttccattatggctgc-3 and W385A rev
5-gcagccataatggaacGCttctatagggcaatc-3) and Pfu Turbo
(Stratagene). PCRproductswere digestedwithDpnI (NewEng-
land Biolabs) and transformed. All constructs were sequence-
verified (Beckman Coulter Genomics).
Immunoprecipitation—COS-7 cells were seeded at 500,000
cells per 100-mm dish and transfected with pCMV 3FLAG-
ING3 wild-type (ING3WT), Y362A (ING3Y362A), or W385A
(ING3W385A) vectors using Mirus LT1 reagent. Cells were har-
vested 72 h post-transfection, resuspended in lysis buffer (50
mMTris-Cl, pH 7.5, 150mMNaCl, 0.2mMNa3VO4, 1%Nonidet
P-40, 1 mM PMSF, 1 mM DTT, and protease inhibitors (Roche
Applied Science)), incubatedwith anti-FLAGantibody (M2clone,
Sigma) for 16 h at 4 °C, and immunoprecipitated using Protein
G-Sepharose beads (GE Healthcare). Immunoprecipitates were
analyzed by immunoblotting with anti-TRRAP (Abcam), anti-
TIP60 (SCBT), or anti-FLAG (Sigma) antibodies.
Retroviral Expression—HEK293T cells (3 million cells per
100-mm dish) were transfected with 9 g of indicated pMF
constructs (empty, ING3WT, ING3Y362A, or ING3W385A) and
4.5g of eachVSV-G and gag/pol expressing plasmids using 54
l of TransIT-LT1 reagent (Mirus). The medium was changed
24 h post-transfection, and supernatants collected at 48 and
72 h post-transfection were filtered (Millipore Millex-HV
0.45-m PVDF filters) and concentrated (Millipore Amicon
Ultra-15).
Flow Cytometry Analysis—MCF7 cells were transduced with
the indicated retroviral particles in the presence of Polybrene (8
g/ml). The next day, the medium was refreshed. After 48 h,
puromycin selection (1 g/ml) was applied for 24 h. Cell cycle
profiles were assessed as described previously (68). Briefly,
MCF7 cells were re-suspended in a propidium iodide staining
mixture (0.8% Triton X-100, 50 g/ml propidium iodide, and
75 g/ml RNase A) and incubated for 10 min at room temper-
ature. Apoptosis was assessed by staining with annexin VAlexa
Fluor488 and propidium iodide (Life Technologies, Inc.,
V13241). Stained cells were immediately injected into a FAC-
SCalibur; 10,000 cells were analyzed per sample.
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